Taejoon Pharmaceutical Co., Ltd.
Seoul, South Korea
NCT Number: NCT03544944
This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Seoul, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects who are randomized into group TJP-008-1 will receive bowel preparation on the same-day.
Subjects who are randomized into group TJP-008-2 will receive bowel preparation from evening to next morning.
Subjects who are randomized into group Coolprep will receive bowel preparation from evening to next morning.
Time frame: 1 day of scheduled colonoscopy
Time frame: 1 day of scheduled colonoscopy
Taejoon Pharmaceutical Co., Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06192394
Behavior, Bowel Preparation
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06994585
Bowel Preparation
New Taipei City, Taiwan
View Trial DetailsNCT06444724
Bowel Preparation, Colonoscopy
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT05088408
Bowel Preparation, Colonoscopy
Coimbra, Coimbra District, Portugal
View Trial Details